Evidence map›Paper›PMID 37116051›Full record

ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2023

[Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis].

A Puplà Bartoll, M D Bellés Medall, I E Pérez Catalán, C Roig Martí, J Bodega Azuara, M Gil Candel, V Esteve López, R Ferrando Piqueres

Open access · diamondAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. [Pharmacokinetic interaction between linezolid and rifampicin: A case report].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A Puplà BartollAaron Puplà Bartoll, Farmacia Hospitalaria, Hospital General Universitario de Castellón, Castellón de la Plana, Spain. pupla_aar@gva.es.
M D Bellés Medall
I E Pérez Catalán
C Roig Martí
J Bodega Azuara
M Gil Candel
V Esteve López
R Ferrando Piqueres
Hospital General Universitari de Castelló · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EndocarditisEndocarditis, BacterialStaphylococcal InfectionsAnti-Bacterial AgentsHumansLinezolidRifampinAnti-Bacterial AgentsLinezolidRifampinCYP2J2EndocarditisLinezolidPharmacokineticsRifampicin

Identifiers

PMID37116051
PMCPMC10336317
OpenAlexW4367308576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.